Asthma Drugs Market Growth Accelerates: Strategic Forecast Predicts $31.38 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Asthma Drugs Industry Market Size Be by 2025?
In the past few years, the longevity of the asthma medications market has been systematically expanding. This market, which worth $23.96 billion in 2024, will surge to $24.93 billion in 2025, registering a compound annual growth rate (CAGR) of 4.0%. The burgeoning growth during the historical period can be linked to environmental influences, the rise in respiratory diseases, shifts in lifestyle patterns, and the advancement in healthcare infrastructure.

What's the Long-Term Growth Forecast for the Asthma Drugs Market Size Through 2029?
In the upcoming years, the asthma medication market is projected to witness robust expansion, reaching an estimated worth of $31.38 billion by 2029 at a CAGR of 5.9%. The forecast period's growth can be held accountable to factors such as escalating levels of air pollution, the rising elderly population, enhanced healthcare awareness, trends towards personalized medicine, and innovations in the biopharmaceutical field. Notable trends expected to emerge in the forecast period encompass small molecule therapies, home-centered asthma treatment, therapies guided by biomarkers, advancements in severe asthma treatment, and collaborative efforts in asthma research.

View the full report here:
https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

What Are the Key Growth Drivers Fueling the Asthma Drugs Market Expansion?
Rising rates of asthmatic conditions are predicted to drive the expansion of the asthma drug market. Asthma, a chronic illness that triggers inflammation and swelling in the airways, results in the constriction of the pathways that funnel air from the nose and mouth into the lungs. The growth in asthma incidences has led to the discovery of novel asthma medications to manage these conditions. For example, in April 2024, Asthma + Lung UK, a charity based in England supporting individuals with lung diseases, reported that in 2021, there were 1,146 asthma-related deaths in England. This number escalated in 2022, reaching 1,236, exhibiting an alarming increase in deaths linked to this illness throughout the year.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11924&type=smp

What Are the Key Trends Driving Asthma Drugs Market Growth?
Major corporations in the asthma medications market are concentrating efforts on cutting-edge innovations like fixed-dose combination (FDC) drugs, with the goal of increasing treatment effectiveness and patient compliance. An FDC drug combines two or more active substances in a single dose format, like a pill, capsule, or inhaler. For example, Glenmark Pharmaceuticals, a company from India, launched Indamet in June 2022 - a novel FDC drug available in India for individuals suffering from uncontrolled asthma. This revolutionary remedy combines Indacaterol, a long-acting beta-agonist, with Mometasone Furoate, an inhaled corticosteroid, and comes in several strengths including Indacaterol 150 mcg along with Mometasone at doses of 80 mcg, 160 mcg, and 320 mcg. Created for once-a-day use, Indamet is intended for adults and young adults aged 12 and up.

How Is the Asthma Drugs Market Segmented?
The asthma drugs market covered in this report is segmented -

1) By Type Of Asthma: Allergic, Non-Allergic
2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma
3) By Therapy: Preventive, Curative
4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs
5) By End-User: Asthma Patients, COPD Patients

Subsegments:
1) By Allergic: Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies
2) By Non-Allergic: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11924&type=smp

Which Companies Are Leading the Charge in Asthma Drugs Market Innovation?
Major companies operating in the asthma drugs market include Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Ltd, Innoviva Inc., Vectura Group, Circassia Group PLC, Pulmatrix Inc., Atopix Therapeutics Limited

Which Regions Are Leading the Global Asthma Drugs Market in Revenue?
North America was the largest region in the asthma drugs market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11924

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.